Markets Leerink Partners analyst Geoff Porges maintained a Hold rating on Radius Health (RDUS – Research Report) on April 22. The company’s shares closed last Friday at $20.90. According to TipRanks.com, Porges is a 3-star analyst with an average return of 5.9% and a 49.5% success rate. Porges covers the Healthcare sector, focusing on stocks such as Alexion Pharmaceuticals, Vertex Pharmaceuticals, and Theravance Biopharma. Radius Health has an analyst consensus of Moderate Buy, with a price target consensus of $29.00. Radius Health’s market cap is currently $980.1M and has a P/E ratio of -8.50. The company has a Price to Book ratio of -7.25.